Summary
Moderna co-founder Robert Langer has regained his billionaire status after Moderna's stock more than doubled following positive results from a late-stage trial of an mRNA-based cancer therapy developed with Merck.
Moderna co-founder Robert Langer is a billionaire again as stock more than doubles
HyperFast News
Related news
Moderna Stock Plunges 25%, Wiping Out $18 Billion Despite Cancer Vaccine Breakthrough
15 Sept 2026, 6:27 am · News
Moderna's 177% Surge Causes $5.5 Billion Loss for Short Sellers
15 Sept 2026, 6:27 am · News
Moderna Co-Founder Robert Langer Becomes Billionaire Again as Shares Double
15 Sept 2026, 6:27 am · News
